Literature DB >> 20930563

Pandemic influenza A 2009 (H1N1) vaccination in high risk children with chronic renal diseases: acceptance and perceptions.

Nikoleta Printza1, Evagelia Farmaki, Julia Bosdou, Chrysa Gkogka, Fotios Papachristou.   

Abstract

We aimed to evaluate the acceptance of pandemic influenza A 2009 vaccination in our high risk children with chronic renal diseases. A total of 64 children/parents of pediatric nephrology department were approached to fill in a standardised questionnaire on influenza immunization profile. The H1N1 vaccination rates were 57.1% for transplant recipients, 61.5% for patients on peritoneal dialysis (PD), 36.4% for patients with various stages of chronic renal disease (CRD) and 26.7% for patients with glomerulonephritis (GN) on immunosuppressive therapy. Children on renal transplantation or PD had a fourfold higher rate of being vaccinated than children with GN (p=0.04). Causes of denying vaccination included fear of adverse effects (48.9%), lack of sufficient data on the new vaccine (31.9%) and others (19.2%). Patients being vaccinated were all urged by their pediatric nephrologist (100%), while patients not vaccinated were negatively influenced by media (41.4%), friends (24.1%), pediatrician (20.7%) and others (13.8%). Regarding parents education, higher level was associated with increased rate of children vaccination (p=0.04). It seems that patients with severe renal disease had better compliance with vaccination. The pediatric nephrologists had the most significant positive influence in contrast to the media which had the most negative influence.

Entities:  

Mesh:

Year:  2010        PMID: 20930563     DOI: 10.4161/hv.6.10.12846

Source DB:  PubMed          Journal:  Hum Vaccin        ISSN: 1554-8600


  5 in total

1.  Neighborhood determinants of 2009 pandemic A/H1N1 influenza vaccination in Montreal, Quebec, Canada.

Authors:  Stephanie Brien; Jeffrey C Kwong; Katia M Charland; Aman D Verma; John S Brownstein; David L Buckeridge
Journal:  Am J Epidemiol       Date:  2012-10-16       Impact factor: 4.897

Review 2.  Protecting pediatric oncology patients from influenza.

Authors:  Leslie S Kersun; Anne F Reilly; Susan E Coffin; Kathleen E Sullivan
Journal:  Oncologist       Date:  2013-01-31

3.  Reasons of the delayed vaccination, recommendations and safety of vaccination in children with congenital heart disease in Zhejiang, China.

Authors:  Mingyan Li; Chai Ji; Yan Zeng; Dan Yao; Xia Wang; Jie Shao
Journal:  Hum Vaccin Immunother       Date:  2021-02-12       Impact factor: 3.452

4.  Clinic accessibility and clinic-level predictors of the geographic variation in 2009 pandemic influenza vaccine coverage in Montreal, Canada.

Authors:  Katia M Charland; Luc de Montigny; John S Brownstein; David L Buckeridge
Journal:  Influenza Other Respir Viruses       Date:  2014-01-02       Impact factor: 4.380

Review 5.  Gaps in knowledge about the vaccine coverage of immunocompromised children: a scoping review.

Authors:  Shannon E MacDonald; Airlie Palichuk; Linda Slater; Hailey Tripp; Laura Reifferscheid; Catherine Burton
Journal:  Hum Vaccin Immunother       Date:  2021-07-16       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.